Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

NCT01597973 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01597973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01597973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
Lead sponsor
University of Michigan
Phase
Phase 3
Overall status
Completed
Start date
October 6, 2012
Completion date
August 9, 2020
Enrollment
467 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

blood stream infection, pneumonia